Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hologic Inc.
Hologic has agreed to pay $80m in cash, plus contingent payments for Acessa, a privately held developer of minimally invasive treatments for uterine fibroids.
Three years after the US FDA released a guidance to use real-world evidence in premarket applications, the stakeholder group MDIC has unveiled a framework for how IVD RWE can be captured and used by sponsors for premarket applications.
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
The US government is helping Sonica develop ADAM, a patch monitor that tracks the user's breathing patterns and other physiologic signals to detect SARS-CoV-2 infections.
- Contract Research, Toxicology Testing-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- Acessa Health Inc.
- Cytyc Corporation
- Faxitron Bioptics, LLC
- Focal Therapeutics, Inc.
- Gen-Probe Inc.
- Interlace Medical Inc.
- Palomar Medical Techologies
- SuperSonic Imagine
- Third Wave Technologies